An interventional study of Video-Guided Acupuncture Imagery Treatment (VGAIT) in Chemotherapy-induced Peripheral Neuropathy, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-22.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Supportive care
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
We will perform a pilot study to assess the feasibility of Video-Guided Acupuncture Imagery Treatment (VGAIT) on CIPN symptoms in patients with stage I-III breast cancer with persistent CIPN after adjuvant chemotherapy. Participants will receive 16 sessions of VGAIT over 8 weeks remotely through the zoom. Study measures will be collected at the time of study enrollment, week 4, and week 8. The primary endpoints of the study will be 1) retention to treatment; 2) satisfaction for the intervention and 3) completion of study assessments.
Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Video-Guided Acupuncture Imagery Treatment (VGAIT)
Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them
Feasibility related outcomes
Completion, satisfaction
Time frame: 8 week
Patient Neurotoxicity Questionnaire (PNQ)
A tool designed to assess neurotoxic effects in patients who have undergone treatments such as chemotherapy
Time frame: baseline, 8 week
Functional Assessment of Cancer Therapy-Neurotoxicity subscale (FACT-NTX)
a widely used, validated instrument that assesses the impact of neuropathy on health-related quality of life
Time frame: baseline, 8 week
Brief Pain Inventory-short form (BPI-SF)
An instrument used to evaluate the severity of pain, including neuropathic pain, and the impact on the patient's daily functioning.
Time frame: baseline, 8 week
European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 (QLQ-C30) instrument
an instrument developed to assess the quality of life in cancer patients
Time frame: baseline, 8 week
MGH Acupuncture Sensation Scale (MASS)
scale includes 12 descriptors of sensations frequently described during acupuncture treatment
Time frame: after each intervention
Pain Catastrophizing Scale (PCS)
a 13-item self-report scale which measures pain-related rumination, magnification, and helplessness
Time frame: baseline, 8 week
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital